首页> 外文OA文献 >Ayurveda in critical care: Illustrating Ayurvedic intervention in a case of hepatic encephalopathy
【2h】

Ayurveda in critical care: Illustrating Ayurvedic intervention in a case of hepatic encephalopathy

机译:阿育吠陀在重症监护中的应用:说明在肝性脑病病例中的阿育吠陀干预

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ayurvedic interventions have largely been considered helpful in chronic debilitating conditions where active management of a clinical condition is not required. It is for this notion; Ayurvedic therapies have never been approached in any critical care condition requiring an active management. A perception that herbo-metallic components of various Ayurvedic drugs may actually harm the patients who are in compromised vital status has further added to this apprehension against use of such medicines in critical care. Contrary to the conventional belief, we observed a case of grade three hepatic encephalopathy with severely compromised liver function that was successfully treated with Ayurvedic therapy containing many heavy metal containing compounds. The liver function got improved in this case following the Ayurvedic intervention. The symptomatic improvements in this case were also identifiable through biochemical tests showing the functional status of liver. This case therefore is worthy of taking a note for possible inclusion of Ayurvedic interventions in critical care where Ayurvedic therapies are discarded without being given a chance of getting evaluated.
机译:阿育吠陀干预在很大程度上被认为对不需要主动管理临床状况的慢性衰弱状况有帮助。就是为了这个概念;在需要积极管理的任何重症监护条件下,从未采用过阿育吠陀疗法。人们认为,各种阿育吠陀药物中的含金属成分实际上可能会损害处于危重生命状态的患者,这使人们对在重症监护中不使用此类药物的认识进一步加深了。与传统观念相反,我们观察到一例肝功能严重受损的三级肝性脑病,该病已通过含许多重金属化合物的阿育吠陀疗法成功治疗。在这种情况下,通过阿育吠陀干预,肝功能得到改善。这种情况下的症状改善也可以通过显示肝脏功能状态的生化检查确定。因此,此案例值得一提,可能将阿育吠陀干预措施纳入重症监护,因为在这种情况下,放弃阿育吠陀疗法而没有机会进行评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号